Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization

Infection and Immunity

Volumn 64, Issue 6, 1996, Pages 1900-1905

  Chen, Dexiang ^a,b   Mcmichael, John C ^a   Vandermeid, Karl R ^a   Hahn, Denise ^a   Mininni, Terri ^a   Cowell, James ^a   Eldridge, John ^a  

^a Lederle Praxis Biologicals   (United States)

^b Lederle Praxis Biologicals ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; OUTER MEMBRANE PROTEIN; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL PERMEATION CHROMATOGRAPHY; GUINEA PIG; IMMUNIZATION; ION EXCHANGE; LARYNGITIS; LUNG CLEARANCE; MORAXELLA CATARRHALIS; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; PROTEIN PURIFICATION; RESPIRATORY TRACT INFECTION;

EID: 0029934422     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.6.1900-1905.1996     Document Type: Article

References (31)

1. Ahmed, K., H. Masaki, T. C. Dai, A. Ichinose, Y. Utsunomiya, M. Tao, T. Nagatake, and K. Matsumoto. 1994. Expression of fimbriae and host response in Branhamella catarrhalis respiratory infections. Microbiol. Immunol. 38:767-771.
2. Ahmed, K., N. Rikitomi, T. Nagatake, and K. Matsumoto. 1992. Ultrastructure study on the adherence of Branhamella catarrhalis to otopharyngeal epithelial cells. Microbiol. Immunol. 36:563-573.
3. Bluestone, C. D., J. S. Stephenson, and L. M. Martin. 1992. Ten-year review of otitis media pathogens. Pediatr. Infect. Dis. J. 11:S7-S11.
4. Catlin, B. W. 1990. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin. Microbiol. Rev. 3:293-320.
5. Chapman, A. J., D. M. Musher, S. Jonsson, J. E. Clarridge, and R. J. Wallace. 1985. Development of bactericidal antibody during Branhamella catarrhalis infection. J. Infect. Dis. 115:878-882.
6. Chen, D., J. McMichael, K. VanDerMeid, D. Hahn, R. Smith, J. Eldridge, and J. Cowell. 1995. Antibodies to the UspA outer membrane protein of Moraxella catarrhalis block bacterial attachment in vitro and are protective in a murine pulmonary challenge model, abstr. E-53, p. 290. In Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C.
7. Christensen, J. J., J. Renneberg, B. Bruun, and A. Forsgren. 1995. Serum antibody response to proteins of Moraxella (Branhamella) catarrhalis in patients with lower respiratory tract infection. Clin. Diagn. Lab. Immunol. 2:14-17.
8. Davies, B. I., and F. P. V. Maesen. 1988. The epidemiology of respiratory tract pathogens in Southern Netherlands. Eur. Respir. J. 1:415-420.
9. DiGiovanni, C., T. V. Riley, G. F. Hoyne, R. Yeo, and P. Cooksey. 1987. Respiratory infections due to Branhamella catarrhalis: epidemiological data from Western Australia. Epidemiol. Infect. 99:445-453.
10. Doyle, W. J. 1989. Animal models of otitis media: other pathogens. Pediatr. Infect. Dis. J. 8(Suppl.):S45-S47.
11. Ejlertsen, T. 1991. Pharyngeal carriage of Moraxella (Branhamella) catarrhalis in healthy adults. Eur. J. Clin. Microbiol. Infect. Dis. 10:89.
12. Faden, H., Y. Harabuchi, J. J. Hong, and Tonawanda/Williamsville Pediatrics. 1994. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J. Infect. Dis. 169:1312-1317.
13. Fung, C. P., S. F. Yeo, and D. M. Livermore. 1994. Susceptibility of Moraxella catarrhalis isolates to beta-lactam antibiotics in relation to beta-lactamase pattern. J. Antimicrob. Chemother. 33:215-222.
14. Goldblatt, D., M. Turner, and R. Levinsky. 1990. Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J. Infect. Dis. 162:1128-1135.
15. Helminen, M. E., R. Beach, I. Maciver, G. Jarosik, E. J. Hansen, and M. Leinonen. 1995. Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay. Clin. Diagn. Lab. Immunol. 2:35-39.
16. Helminen, M. E., I. Maciver, J. L. Latimer, L. D. Cope, G. H. McCracken, and E. J. Hansen. 1993. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect. Immun. 61:2003-2010.
17. Helminen, M. E., I. Maciver, J. L. Latimer, J. Klesney-Tait, L. D. Cope, M. Paris, G. H. McCracken, and E. J. Hansen. 1994. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J. Infect. Dis. 170:867-872.
18. Klingman, K. L., and T. F. Murphy. 1994. Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect. Immun. 62:1150-1155.
19. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
20. Maciver, I., M. Unhanand, G. H. McCracken, and E. J. Hansen. 1993. Effect of immunization on pulmonary clearance of Moraxella catarrhalis in an animal model. J. Infect. Dis. 168:469-472.
21. Murphy, T. F., and L. C. Bartos. 1989. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infect. Immun. 57:2938-2941.
22. Murphy, T. F., C. Kirkham, and A. J. Lesse. 1993. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis. Mol. Microbiol. 10:87-97.
23. Murphy, T. F., and M. R. Loeb. 1989. Isolation of the outer membrane of Branhamella catarrhalis. Microb. Pathog. 6:159-174.
24. Onofrio, J. M., A. N. Shulkin, P. J. Heidbrink, G. B. Toews, and A. K. Pierce. 1981. Pulmonary clearance and phagocytic cell response to normal pharyngeal flora. Am. Rev. Respir. Dir. 123:222-225.
25. Ruuskanen, O., and T. Heikkinen. 1994. Otitis media: etiology and diagnosis. Pediatr. Infect. Dis. J. 13:S23-S26.
26. Sarubbi, F. A., J. W. Myers, J. J. Williams, and C. G. Shell. 1990. Respiratory infections caused by Branhamella catarrhalis. Selected epidemiologic features. Am. J. Med. 88(Suppl. 5A):9S-14S.
27. Schalen, L., I. Eliasson, S. Fex, C. Kamme, and C. Schalen. 1992. Acute laryngitis in adults: results of erythromycin treatment. Acta Otolaryngol. Suppl. (Stockholm) 492:55-57.
28. Schalen, L., I. Eliasson, C. Kamme, and C. Schalen. 1993. Erythromycin in acute laryngitis in adults. Ann. Otol. Rhinol. Laryngol. 102:209-214.
29. Unhanand, M., I. Maciver, O. Ramilo, O. Arencibia-Mireles, J. C. Argyle, G. H. McCracken, and E. J. Hansen. 1992. Pulmonary clearance of Moraxella catarrhalis in an animal model. J. Infect. Dis. 165:644-650.
30. Vaneechoutte, M., G. Verschraegen, G. Claeys, B. Weise, and A. M. Van Den Abeele. 1990. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J. Clin. Microbiol. 28:2674-2680.
31. Verghese, A., E. Berro, J. Berro, and B. W. Franzus. 1990. Pulmonary clearance and phagocytic cell response in a murine model of Branhamella catarrhalis. J. Infect. Dis. 162:1189-1192.